levothyroxine sodium
- Product NDC
- 71335-1438
- 11-digit product format
- 713351438
- Labeler code
- 71335
- Product ID
- 71335-1438_5dd258ee-53fd-4e60-b3c9-b3cfacd622bf
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- levothyroxine sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- NDA021116
- Marketing category
- NDA
- Marketing start
- 2019-05-07
- Substance
- LEVOTHYROXINE SODIUM
- Active strength
- 88 ug/1
- Pharmacologic classes
- Thyroxine [CS], l-Thyroxine [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- levothyroxine sodium
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LEVOTHYROXINE SODIUM | 88 ug/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 9J765S329G |
| Rxcui | 892246, 892251, 966220, 966221, 966222, 966224, 966225, 966248, 966249, 966253, 966270 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-1438-1 | 71335143801 | 30 TABLET in 1 BOTTLE (71335-1438-1) | 30 tablet | 2019-12-16 | 0000-00-00 | No | No | Current |
| 71335-1438-2 | 71335143802 | 90 TABLET in 1 BOTTLE (71335-1438-2) | 90 tablet | 2019-12-16 | 0000-00-00 | No | No | Current |
| 71335-1438-3 | 71335143803 | 28 TABLET in 1 BOTTLE (71335-1438-3) | 28 tablet | 2019-12-16 | 0000-00-00 | No | No | Current |
| 71335-1438-4 | 71335143804 | 100 TABLET in 1 BOTTLE (71335-1438-4) | 100 tablet | 2019-12-16 | 0000-00-00 | No | No | Current |
| 71335-1438-5 | 71335143805 | 60 TABLET in 1 BOTTLE (71335-1438-5) | 60 tablet | 2019-12-16 | 0000-00-00 | No | No | Current |